Cerebrospinal fluid metabolomic and postpartum depression: A Mendelian randomization study

Area of Science:

• Neuroscience
• Metabolomics
• Genetics

Background:

• Postpartum depression (PPD) is a significant mental health challenge with potential metabolic underpinnings.
• Cerebrospinal fluid (CSF) metabolites are increasingly recognized as playing a role in neurological disorders.
• Understanding the interplay between genetics, metabolites, and PPD is crucial for developing targeted interventions.

Purpose of the Study:

• To investigate the causal relationships between CSF metabolites and PPD using a bi-directional Mendelian randomization (MR) approach.
• To identify specific CSF metabolites that may influence the risk or provide protection against PPD.
• To explore the genetic architecture connecting CSF metabolites and PPD.

Main Methods:

• Employed a bi-directional Mendelian randomization (MR) framework analyzing 338 CSF metabolites and PPD.
• Utilized genome-wide association study data from European descendants for maternal PPD diagnosis and CSF metabolite profiles.
• Applied robust statistical methods including inverse variance weighting, weighted median, and mode-based estimation.

Main Results:

• Identified several CSF metabolites causally associated with PPD.
• Metabolites like 3-hydroxy-3-methylglutarate, 3-methoxytyrosine, and argininosuccinate showed a protective association with PPD.
• Arachidonate, benzoate, and carnitine were associated with an increased risk of PPD, with consistent findings across MR methods.

Conclusions:

• CSF metabolomics offers a promising avenue for understanding the etiology of PPD.
• Specific CSF metabolites are implicated in the risk and protective factors of PPD.
• These findings pave the way for future research into novel therapeutic strategies for PPD based on metabolic pathways.